Pure Global

RACTIVO PARA DETERMINACIÓN DE GLUCOSA - COFEPRIS Registration 0441R2022 SSA

Access comprehensive regulatory information for RACTIVO PARA DETERMINACIÓN DE GLUCOSA (RACTIVO PARA DETERMINACIÓN DE GLUCOSA) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 0441R2022 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on May 31, 2022.

This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.

Free Database
Powered by Pure Global AI
COFEPRIS Official Data
Clase I
0441R2022 SSA
RACTIVO PARA DETERMINACIÓN DE GLUCOSA
COFEPRIS Analysis ID: 0441R2022 SSA
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class / Clase de Riesgo
Clase I
Product Type (Spanish)
III. Agentes de diagnóstico
Product Type (English)
III. Agentes de diagnóstico
Trade Name (Spanish)
HBA1C ADVANCED HEMOGLOBINA A1C
Trade Name (English)
HBA1C ADVANCED HEMOGLOBINA A1C
Registration Information
Analysis ID
0441R2022 SSA
Registration Date
May 31, 2022
Manufacturer / Fabricante
Name (English)
BECKMAN COULTER DE MÉXICO, S.A. DE C.V.